These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 9445924)
21. Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study. de Kleijn ED; de Groot R; Hack CE; Mulder PG; Engl W; Moritz B; Joosten KF; Hazelzet JA Crit Care Med; 2003 Jun; 31(6):1839-47. PubMed ID: 12794428 [TBL] [Abstract][Full Text] [Related]
22. Mutilating Purpura Fulminans in an Adult with Meningococcal Sepsis. Arnáiz-García ME; Arnáiz-García AM; Gutierrez-Diez F; Nistal JF; González-Santos JM; Pulitani I; Amado-Diago C; Arnáiz J P R Health Sci J; 2017 Sep; 36(3):179-182. PubMed ID: 28915308 [TBL] [Abstract][Full Text] [Related]
23. [Prospects of thrombolytic therapy for acute ischemic stroke]. Nakashima T; Minematsu K Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399 [TBL] [Abstract][Full Text] [Related]
24. Meningococcal septicaemia complications involving skin and underlying deeper tissues--management considerations and outcome. Numanoglu A; Bickler SW; Rode H; Bosenberg AT S Afr J Surg; 2007 Nov; 45(4):142-6. PubMed ID: 18069582 [TBL] [Abstract][Full Text] [Related]
25. Use of recombinant tissue plasminogen activator in children with meningococcal purpura fulminans: a retrospective study. Zenz W; Zoehrer B; Levin M; Fanconi S; Hatzis TD; Knight G; Müllner M; Faust SN; Crit Care Med; 2004 Aug; 32(8):1777-80. PubMed ID: 15286558 [TBL] [Abstract][Full Text] [Related]
27. Gut mucosal cell damage in meningococcal sepsis in children: relation with clinical outcome. Derikx JP; Bijker EM; Vos GD; van Bijnen AA; Heineman E; Buurman WA; van Waardenburg DA Crit Care Med; 2010 Jan; 38(1):133-7. PubMed ID: 19730255 [TBL] [Abstract][Full Text] [Related]
28. [Replacement therapy with protein C for meningococcal sepsis and fulminant purpura in pediatric patients]. Llinares Tello F; Hernández Prats C; Burgos San José A; Bosacoma Ros N; Alcalá Minagorre P; López Rodríguez F; Reig Sáenz R; Marco Vera P; Ordovás Baines JP Farm Hosp; 2004; 28(2):130-6. PubMed ID: 15101805 [TBL] [Abstract][Full Text] [Related]
29. Meningococcal sepsis in children: persistent problem; new insights? Ackerman A Crit Care Med; 2010 Jan; 38(1):316-7. PubMed ID: 20023480 [No Abstract] [Full Text] [Related]
30. Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminans. Nadel S; De Munter C; Britto J; Habibi P; Levin M Crit Care Med; 1998 May; 26(5):971-2; author reply 972-3. PubMed ID: 9590331 [No Abstract] [Full Text] [Related]
31. [Assessment of severity of meningococcal sepsis in children]. Oom P; Rossi R; Correia M; Rodrigues G Acta Med Port; 2003; 16(5):321-6. PubMed ID: 14750274 [TBL] [Abstract][Full Text] [Related]
32. Effects of increased liver blood flow on the kinetics and dynamics of recombinant tissue-type plasminogen activator. van Griensven JM; Huisman LG; Stuurman T; Dooijewaard G; Kroon R; Schoemaker RC; Kluft K; Cohen AF Clin Pharmacol Ther; 1996 Nov; 60(5):504-11. PubMed ID: 8941023 [TBL] [Abstract][Full Text] [Related]
33. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935). Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138 [TBL] [Abstract][Full Text] [Related]
34. Recombinant tissue-type plasminogen activator in acute myocardial infarction: role of the critical care nurse. Kline EM Heart Lung; 1987 Nov; 16(6 Pt 2):779-86. PubMed ID: 2960639 [No Abstract] [Full Text] [Related]
35. Thrombolytic therapy in children--clinical experiences with recombinant tissue-plasminogen activator. Knöfler R; Dinger J; Kabus M; Müller D; Lauterbach I; Rupprecht E; Taut-Sack H; Weissbach G Semin Thromb Hemost; 2001; 27(2):169-74. PubMed ID: 11372772 [TBL] [Abstract][Full Text] [Related]
36. [Cytokine inhibitors in intensive care]. Villard J; Jolliet P; Chevrolet JC Rev Mal Respir; 1995; 12(4):335-42. PubMed ID: 7481045 [TBL] [Abstract][Full Text] [Related]
37. [Local thrombolytic treatment of spontaneous intracerebral hemorrhage with plasminogen activator (rt-PA). Indications and limits]. Schaller C; Rohde V; Hassler W Nervenarzt; 1995 Oct; 66(10):792. PubMed ID: 7501098 [No Abstract] [Full Text] [Related]
38. Accelerated intravenous dosing of recombinant tissue-type plasminogen activator causes rapid but unstable reperfusion in a canine model of acute myocardial infarction. Gurbel PA; Anderson RD; MacCord CS; Scott H; Serebruany V; Herzog WR Coron Artery Dis; 1994 Nov; 5(11):929-36. PubMed ID: 7719525 [TBL] [Abstract][Full Text] [Related]
39. [Local thrombolytic treatment of spontaneous intracerebral hemorrhage with plasminogen activator (rt-PA). Indications and limits]. Schaller C; Rohde V; Hassler W Nervenarzt; 1995 Apr; 66(4):275-81. PubMed ID: 7783814 [TBL] [Abstract][Full Text] [Related]